ReviewCancers2020

Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized Trials.

Francesco Facchinetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.